loadpatents
Patent applications and USPTO patent grants for Holson; Edward.The latest application filed is for "kinase inhibitors and methods of use thereof".
Patent | Date |
---|---|
Inhibitors of histone deacetylase Grant 11,377,423 - Holson , et al. July 5, 2 | 2022-07-05 |
Kinase Inhibitors And Methods Of Use Thereof App 20220160702 - Wagner; Florence Fevrier ;   et al. | 2022-05-26 |
Tricyclic Compounds As Glycogen Synthase Kinase 3 (gsk3) Inhibitors And Uses Thereof App 20220112216 - Wagner; Florence Fevrier ;   et al. | 2022-04-14 |
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof Grant 11,203,601 - Wagner , et al. December 21, 2 | 2021-12-21 |
Kinase inhibitors and methods of use thereof Grant 11,052,080 - Wagner , et al. July 6, 2 | 2021-07-06 |
Combination Of A Selective Histone Deacetylase 3 (hdac3) Inhibitor And An Immunotherapy Agent For The Treatment Of Cancer App 20210177781 - Holson; Edward ;   et al. | 2021-06-17 |
Dopamine D2 Receptor Ligands App 20210147355 - Holson; Edward ;   et al. | 2021-05-20 |
Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors Grant 10,793,538 - Holson , et al. October 6, 2 | 2020-10-06 |
Dopamine D2 receptor ligands Grant 10,752,588 - Holson , et al. A | 2020-08-25 |
Inhibitors of histone deacetylase Grant 10,662,199 - Holson , et al. | 2020-05-26 |
Dopamine D2 receptor ligands Grant 10,633,336 - Holson , et al. | 2020-04-28 |
Fluorescent substrates for determining lysine modifying enzyme activity Grant 10,626,438 - Zhang , et al. | 2020-04-21 |
Tricyclic Compounds As Glycogen Synthase Kinase 3 (gsk3) Inhibitors And Uses Thereof App 20200109154 - Wagner; Florence Fevrier ;   et al. | 2020-04-09 |
Kinase Inhibitors And Methods Of Use Thereof App 20200061050 - Wagner; Florence Fevrier ;   et al. | 2020-02-27 |
Dopamine D2 Receptor Ligands App 20190345105 - Holson; Edward ;   et al. | 2019-11-14 |
Combination Of A Selective Histone Deacetylase 3 (hdac3) Inhibitor And An Immunotherapy Agent For The Treatment Of Cancer App 20190216754 - Holson; Edward ;   et al. | 2019-07-18 |
Kinase Inhibitors And Methods Of Use Thereof App 20190175584 - Wagner; Florence Fevrier ;   et al. | 2019-06-13 |
Dopamine D2 Receptor Ligands App 20190023656 - Holson; Edward ;   et al. | 2019-01-24 |
Kinase inhibitors and methods of use thereof Grant 10,137,122 - Wagner , et al. November 27, 2 | 2018-11-27 |
Compounds, substrates and methods related to histone deacetylases Grant 10,125,387 - Holson , et al. November 13, 2 | 2018-11-13 |
Cycloalkenyl Hydroxamic Acid Derivatives And Their Use As Histone Deacetylase Inhibitors App 20180215726 - Holson; Edward ;   et al. | 2018-08-02 |
Dopamine D2 Receptor Ligands App 20180155283 - Holson; Edward ;   et al. | 2018-06-07 |
Fluorescent Substrates For Determining Lysine Modifying Enzyme Activity App 20180155760 - Zhang; Yan-Ling ;   et al. | 2018-06-07 |
Inhibitors Of Histone Deacetylase App 20180099977 - Holson; Edward ;   et al. | 2018-04-12 |
Inhibitors Of Histone Deacetylase App 20180072671 - Holson; Edward ;   et al. | 2018-03-15 |
Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors Grant 9,914,717 - Holson , et al. March 13, 2 | 2018-03-13 |
Compounds, Substrates And Methods Related To Histone Deacetylases App 20180051314 - Holson; Edward ;   et al. | 2018-02-22 |
Inhibitors of histone deacetylase Grant 9,890,172 - Holson , et al. February 13, 2 | 2018-02-13 |
Inhibitors Of Histone Deacetylase App 20180016282 - Holson; Edward ;   et al. | 2018-01-18 |
Fluorescent substrates for determining lysine modifying enzyme activity Grant 9,856,509 - Zhang , et al. January 2, 2 | 2018-01-02 |
Inhibitors of histone deacetylase Grant 9,790,184 - Holson , et al. October 17, 2 | 2017-10-17 |
Compounds, substrates and methods related to histone deacetylases Grant 9,745,613 - Holson , et al. August 29, 2 | 2017-08-29 |
Inhibitors Of Histone Deacetylase App 20170217955 - Holson; Edward ;   et al. | 2017-08-03 |
Modified saponins for the treatment of fungal infections Grant 9,629,865 - Mylonakis , et al. April 25, 2 | 2017-04-25 |
Uses Of Paralog-selective Inhibitors Of Gsk3 Kinases App 20160375006 - Scolnick; Edward ;   et al. | 2016-12-29 |
Inhibitors Of Histone Deacetylase App 20160347761 - Holson; Edward ;   et al. | 2016-12-01 |
Inhibitors of histone deacetylase Grant 9,447,030 - Holson , et al. September 20, 2 | 2016-09-20 |
Inhibitors Of Histone Deacetylase App 20160251351 - Holson; Edward ;   et al. | 2016-09-01 |
Modified Saponins For the Treatment of Fungal Infections App 20160228465 - Mylonakis; Eleftherios ;   et al. | 2016-08-11 |
Inhibitors of histone deacetylase Grant 9,365,498 - Holson , et al. June 14, 2 | 2016-06-14 |
Modified saponins for the treatment of fungal infections Grant 9,320,751 - Mylonakis , et al. April 26, 2 | 2016-04-26 |
Compounds, Substrates And Methods Related To Histone Deacetylases App 20160060679 - Holson; Edward ;   et al. | 2016-03-03 |
Solid forms of tacedinaline Grant 9,266,822 - Holson , et al. February 23, 2 | 2016-02-23 |
Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders Grant 9,265,764 - Haggarty , et al. February 23, 2 | 2016-02-23 |
Cycloalkenyl Hydroxamic Acid Derivatives And Their Use As Histone Deacetylase Inhibitors App 20150368221 - Holson; Edward ;   et al. | 2015-12-24 |
Kinase Inhibitors And Methods Of Use Thereof App 20150313890 - Wagner; Florence Fevrier ;   et al. | 2015-11-05 |
Kinase inhibitors and methods of use thereof Grant 9,096,594 - Wagner , et al. August 4, 2 | 2015-08-04 |
Inhibitors Of Histone Deacetylase App 20150191427 - Holson; Edward ;   et al. | 2015-07-09 |
Modified Saponins for the Treatment of Fungal Infections App 20150182544 - Mylonakis; Eleftherios ;   et al. | 2015-07-02 |
Modified saponins for the treatment of fungal infections Grant 8,987,217 - Mylonakis , et al. March 24, 2 | 2015-03-24 |
Fluorescent Substrates For Determining Lysine Modifying Enzyme Activity App 20140335550 - Zhang; Yan-Ling ;   et al. | 2014-11-13 |
Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders Grant 8,841,346 - Tsai , et al. September 23, 2 | 2014-09-23 |
Novel Solid Forms Of Tacedinaline App 20140275268 - Holson; Edward ;   et al. | 2014-09-18 |
Methods of using novel solid forms of tacedinaline Grant 8,729,130 - Holson , et al. May 20, 2 | 2014-05-20 |
Kinase Inhibitors And Methods Of Use Thereof App 20140107141 - Wagner; Florence Fevrier ;   et al. | 2014-04-17 |
Solid forms of tacedinaline Grant 8,691,875 - Holson , et al. April 8, 2 | 2014-04-08 |
Inhibitors of Histone Deacetylase App 20140080802 - Holson; Edward ;   et al. | 2014-03-20 |
Inhibitors of Histone Deacetylase App 20140080800 - Holson; Edward ;   et al. | 2014-03-20 |
Use of CI-994 and dinaline for the treatment of memory/cognition and anxiety disorders Grant 8,563,615 - Tsai , et al. October 22, 2 | 2013-10-22 |
Novel Solid Forms Of Tacedinaline App 20130150450 - Holson; Edward ;   et al. | 2013-06-13 |
Novel Solid Forms Of Tacedinaline App 20130102677 - Holson; Edward ;   et al. | 2013-04-25 |
Modified Saponins for the Treatment of Fungal Infections App 20130018007 - Mylonakis; Eleftherios ;   et al. | 2013-01-17 |
Use Of Ci-994 And Dinaline For The Treatment Of Memory/cognition And Anxiety Disorders App 20120322879 - Tsai; Li-Huei ;   et al. | 2012-12-20 |
Inhibition Of Hdac2 To Promote Memory App 20120101147 - Tsai; Li-Huei ;   et al. | 2012-04-26 |
Use Of Ci-994 And Dinaline For The Treatment Of Memory/cognition And Anxiety Disorders App 20110224303 - Tsai; Li-Huei ;   et al. | 2011-09-15 |
Uses of chemicals to modulate GSK-3 signaling for treatment of bipolar disorder and other brain disorders App 20110008468 - Haggarty; Stephen J. ;   et al. | 2011-01-13 |
Pyrrolidine and piperidine modulators of chemokine receptor activity Grant 6,166,037 - Budhu , et al. December 26, 2 | 2000-12-26 |
Cycloalkyl tachykinin receptor antagonists Grant 5,750,549 - Caldwell , et al. May 12, 1 | 1998-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.